Antiretrovirals for HIV prevention: when should they be recommended? - Wikidata - awgldk - TriplyDB

Antiretrovirals for HIV prevention: when should they be recommended?

Antiretrovirals for HIV prevention: when should they be recommended?

http://www.wikidata.org/entity/Q38195335

about

The Future of Digital Polymerase Chain Reaction in Virology.

P2860

Q38847659-34BF9ADC-B041-4532-BAA4-7E9D24E9DE06

P2860

Antiretrovirals for HIV prevention: when should they be recommended?

http://www.wikidata.org/entity/Q38195335

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antiretrovirals for HIV prevention: when should they be recommended?

@en

type

label

Antiretrovirals for HIV prevention: when should they be recommended?

@en

prefLabel

Antiretrovirals for HIV prevention: when should they be recommended?

@en

P1433

Q38195335-D4E1E67F-2E8A-487A-BB26-CF25980BB584

P1476

Q38195335-86238E61-62E4-4508-A438-E136197D2D9A

P2093

Q38195335-0221F2C7-97EF-4E06-87FC-B3B98E5A7520

Q38195335-95BA1E93-BE42-4D2E-BFBF-5CF5C73F466E

P2860

Q38195335-07E5FAEC-1802-4B3D-AC14-0AEB210CC3EC

Q38195335-07FCB25C-7723-457B-8BCA-78CB7EA0555B

Q38195335-0AB2B995-04E3-49CA-B2E0-6ED3E727322C

Q38195335-10808BC1-18D8-443A-B9E8-9E7BF0C54FC2

Q38195335-13205AFE-1AE3-40FB-9484-8402683332AA

Q38195335-18F3D19C-A85A-4297-8ECC-5F3BB24E045D

Q38195335-1D6649CD-D89C-41F5-B00F-E2C4F86B1B1D

Q38195335-1EC1CEB2-B422-436C-AEF2-C058C05AA85D

Q38195335-21674242-E02E-4535-86EF-8778230B164F

Q38195335-2C3F0A36-4974-4B97-B66F-D9A496820D72

P304

Q38195335-B21B7C2A-2F64-402B-A519-D92F64ACA464

P31

Q38195335-24314947-587E-4665-B733-6010EE391411

P356

Q38195335-36DC0A87-18C1-492A-BDF5-196B1EC0C9E1

P433

Q38195335-481B9066-DBB7-44E3-8880-6DBF5B773436

P478

Q38195335-7519BEA4-0425-4A96-BDC6-8E477EF4DD09

P50

Q38195335-79B570C8-82C3-4E82-90FD-355FE6913882

Q38195335-CDE63BD8-7F66-426A-B806-6C7B9514FFA5

Q38195335-E1DEC866-C9FC-4DBA-8F5C-35DAD994F801

P577

Q38195335-33B86CA5-00D5-4273-8B78-97F6AEA9612F

P5875

Q38195335-CD2EA16F-A759-41D3-AAAA-BE7120704E93

P698

Q38195335-95E4974B-65F6-470B-9EEA-43A1F7B3DCAA

P921

Q38195335-19288285-F119-43D9-BBD6-65204B63E039

Q38195335-617428C0-85DE-4B4B-A1AB-49D413D52CDA

P356

14787210.2014.896739

P1433

Expert Review of Anti-infective Therapy

P1476

Antiretrovirals for HIV prevention: when should they be recommended?

@en

P2093

Chris Verhofstede

http://www.w3.org/2001/XMLSchema#string

Maja Kiselinova

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

Prevention of HIV-1 infection with early antiretroviral therapy

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Global epidemiology of HIV infection in men who have sex with men

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators

Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study

P304

431-445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2014.896739

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Linos Vandekerckhove

Ward De Spiegelaere

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260756888

http://www.w3.org/2001/XMLSchema#string

P698

24621251

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

prevention of HIV/AIDS